Prolonged exposure to (R)-bicalutamide generates a LNCaP subclone with alteration of mitochondrial genome

Sara Pignatta, Chiara Arienti, Wainer Zoli, Marzia Di Donato, Gabriella Castoria, Elisa Gabucci, Valentina Casadio, Mirella Falconi, Ugo De Giorgi, Rosella Silvestrini, Anna Tesei

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Advanced prostate cancers, initially sensitive to androgen deprivation therapy, frequently progress to the castration-resistant prostate cancer phenotype (CRPC) through mechanisms not yet fully understood. In this study we investigated mitochondrial involvement in the establishment of refractoriness to hormone therapy. Two human prostate cancer cell lines were used, the parental LNCaP and the resistant LNCaP-Rbic, the latter generated after continuous exposure to 20. μM of (R)-bicalutamide, the active enantiomer of Casodex®. We observed a significant decrease in mtDNA content and a lower expression of 8 mitochondria-encoded gene transcripts involved in respiratory chain complexes in both cell lines. We also found that (R)-bicalutamide differentially modulated dynamin-related protein (Drp-1) expression in LNCaP and LNCaP-Rbic cells. These data seem to indicate that the androgen-independent phenotype in our experimental model was due, at least in part, to alterations in mitochondrial dynamics and to a breakdown in the Drp-1-mediated mitochondrial network.

Original languageEnglish
Pages (from-to)314-324
Number of pages11
JournalMolecular and Cellular Endocrinology
Volume382
Issue number1
DOIs
Publication statusPublished - Jan 25 2014

Fingerprint

Mitochondrial Genome
Prostatic Neoplasms
Genes
Androgens
Cells
Mitochondrial Dynamics
Dynamins
Phenotype
Cell Line
Mitochondria
Enantiomers
Castration
Electron Transport
Mitochondrial DNA
Theoretical Models
Hormones
Therapeutics
bicalutamide
Proteins

Keywords

  • (R)-bicalutamide
  • Hormone-resistance
  • Mitochondrial fission
  • MtDNA
  • Prostate cancer

ASJC Scopus subject areas

  • Endocrinology
  • Molecular Biology
  • Biochemistry

Cite this

Prolonged exposure to (R)-bicalutamide generates a LNCaP subclone with alteration of mitochondrial genome. / Pignatta, Sara; Arienti, Chiara; Zoli, Wainer; Di Donato, Marzia; Castoria, Gabriella; Gabucci, Elisa; Casadio, Valentina; Falconi, Mirella; De Giorgi, Ugo; Silvestrini, Rosella; Tesei, Anna.

In: Molecular and Cellular Endocrinology, Vol. 382, No. 1, 25.01.2014, p. 314-324.

Research output: Contribution to journalArticle

Pignatta, Sara ; Arienti, Chiara ; Zoli, Wainer ; Di Donato, Marzia ; Castoria, Gabriella ; Gabucci, Elisa ; Casadio, Valentina ; Falconi, Mirella ; De Giorgi, Ugo ; Silvestrini, Rosella ; Tesei, Anna. / Prolonged exposure to (R)-bicalutamide generates a LNCaP subclone with alteration of mitochondrial genome. In: Molecular and Cellular Endocrinology. 2014 ; Vol. 382, No. 1. pp. 314-324.
@article{5730ffc7202e41088806345a530bc7cd,
title = "Prolonged exposure to (R)-bicalutamide generates a LNCaP subclone with alteration of mitochondrial genome",
abstract = "Advanced prostate cancers, initially sensitive to androgen deprivation therapy, frequently progress to the castration-resistant prostate cancer phenotype (CRPC) through mechanisms not yet fully understood. In this study we investigated mitochondrial involvement in the establishment of refractoriness to hormone therapy. Two human prostate cancer cell lines were used, the parental LNCaP and the resistant LNCaP-Rbic, the latter generated after continuous exposure to 20. μM of (R)-bicalutamide, the active enantiomer of Casodex{\circledR}. We observed a significant decrease in mtDNA content and a lower expression of 8 mitochondria-encoded gene transcripts involved in respiratory chain complexes in both cell lines. We also found that (R)-bicalutamide differentially modulated dynamin-related protein (Drp-1) expression in LNCaP and LNCaP-Rbic cells. These data seem to indicate that the androgen-independent phenotype in our experimental model was due, at least in part, to alterations in mitochondrial dynamics and to a breakdown in the Drp-1-mediated mitochondrial network.",
keywords = "(R)-bicalutamide, Hormone-resistance, Mitochondrial fission, MtDNA, Prostate cancer",
author = "Sara Pignatta and Chiara Arienti and Wainer Zoli and {Di Donato}, Marzia and Gabriella Castoria and Elisa Gabucci and Valentina Casadio and Mirella Falconi and {De Giorgi}, Ugo and Rosella Silvestrini and Anna Tesei",
year = "2014",
month = "1",
day = "25",
doi = "10.1016/j.mce.2013.10.022",
language = "English",
volume = "382",
pages = "314--324",
journal = "Molecular and Cellular Endocrinology",
issn = "0303-7207",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Prolonged exposure to (R)-bicalutamide generates a LNCaP subclone with alteration of mitochondrial genome

AU - Pignatta, Sara

AU - Arienti, Chiara

AU - Zoli, Wainer

AU - Di Donato, Marzia

AU - Castoria, Gabriella

AU - Gabucci, Elisa

AU - Casadio, Valentina

AU - Falconi, Mirella

AU - De Giorgi, Ugo

AU - Silvestrini, Rosella

AU - Tesei, Anna

PY - 2014/1/25

Y1 - 2014/1/25

N2 - Advanced prostate cancers, initially sensitive to androgen deprivation therapy, frequently progress to the castration-resistant prostate cancer phenotype (CRPC) through mechanisms not yet fully understood. In this study we investigated mitochondrial involvement in the establishment of refractoriness to hormone therapy. Two human prostate cancer cell lines were used, the parental LNCaP and the resistant LNCaP-Rbic, the latter generated after continuous exposure to 20. μM of (R)-bicalutamide, the active enantiomer of Casodex®. We observed a significant decrease in mtDNA content and a lower expression of 8 mitochondria-encoded gene transcripts involved in respiratory chain complexes in both cell lines. We also found that (R)-bicalutamide differentially modulated dynamin-related protein (Drp-1) expression in LNCaP and LNCaP-Rbic cells. These data seem to indicate that the androgen-independent phenotype in our experimental model was due, at least in part, to alterations in mitochondrial dynamics and to a breakdown in the Drp-1-mediated mitochondrial network.

AB - Advanced prostate cancers, initially sensitive to androgen deprivation therapy, frequently progress to the castration-resistant prostate cancer phenotype (CRPC) through mechanisms not yet fully understood. In this study we investigated mitochondrial involvement in the establishment of refractoriness to hormone therapy. Two human prostate cancer cell lines were used, the parental LNCaP and the resistant LNCaP-Rbic, the latter generated after continuous exposure to 20. μM of (R)-bicalutamide, the active enantiomer of Casodex®. We observed a significant decrease in mtDNA content and a lower expression of 8 mitochondria-encoded gene transcripts involved in respiratory chain complexes in both cell lines. We also found that (R)-bicalutamide differentially modulated dynamin-related protein (Drp-1) expression in LNCaP and LNCaP-Rbic cells. These data seem to indicate that the androgen-independent phenotype in our experimental model was due, at least in part, to alterations in mitochondrial dynamics and to a breakdown in the Drp-1-mediated mitochondrial network.

KW - (R)-bicalutamide

KW - Hormone-resistance

KW - Mitochondrial fission

KW - MtDNA

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=84887370435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887370435&partnerID=8YFLogxK

U2 - 10.1016/j.mce.2013.10.022

DO - 10.1016/j.mce.2013.10.022

M3 - Article

C2 - 24397920

AN - SCOPUS:84887370435

VL - 382

SP - 314

EP - 324

JO - Molecular and Cellular Endocrinology

JF - Molecular and Cellular Endocrinology

SN - 0303-7207

IS - 1

ER -